Functional distinctions in cytosolic calcium regulation between cells of the glomerular filtration barrier

Cell Calcium

Volumn 48, Issue 1, 2010, Pages 44-53

  Foster, Rebecca Rachael ^a   Welsh, Gavin I ^a   Satchell, Simon C ^a   Marlow, Robin D ^a   Wherlock, Mathew D ^a   Pons, Debora ^a   Mathieson, Peter W ^a   Bates, David O ^a   Saleem, Moin A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Calcium; Flufenamic acid; Glomerular endothelial cells; Podocytes; TRPC6

Indexed keywords

CALCIUM ION; CD16 ANTIGEN; FLUFENAMIC ACID; NEPHRIN; PLASMID VECTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ARTICLE; CALCIUM DEPLETION; CALCIUM SIGNALING; CELL ACTIVATION; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE MUTATION; GENETIC TRANSFECTION; GLOMERULUS FILTRATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 77956010985     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2010.06.005     Document Type: Article

References (43)

1. McDougall P., et al. Action of the nonsteroidal anti-inflammatory agent, flufenamic acid, on calcium movements in isolated mitochondria. Biochem. Pharmacol. 1988, 37(7):1327-1330.
2. Ottolia M., Toro L. Potentiation of large conductance KCa channels by niflumic, flufenamic, and mefenamic acids. Biophys. J. 1994, 67(6):2272-2279.
3. Inoue R., et al. The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca(2+)-permeable cation channel. Circ. Res. 2001, 88(3):325-332.
4. Jung S., et al. TRPC6 is a candidate channel involved in receptor-stimulated cation currents in A7r5 smooth muscle cells. Am. J. Physiol. Cell Physiol. 2002, 282(2):C347-C359.
5. Cheng H.W., et al. VEGF activates receptor-operated cation channels in human microvascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26(8):1768-1776.
6. Hill A.J., et al. A TRPC-like non-selective cation current activated by alpha 1-adrenoceptors in rat mesenteric artery smooth muscle cells. Cell Calcium 2006, 40(1):29-40.
7. Saleh S.N., et al. Angiotensin II activates two cation conductances with distinct TRPC1 and TRPC6 channel properties in rabbit mesenteric artery myocytes. J. Physiol. 2006, 577(Pt 2):479-495.
8. Warren E.J., et al. The light-activated signaling pathway in SCN-projecting rat retinal ganglion cells. Eur. J. Neurosci. 2006, 23(9):2477-2487.
9. 2+ exchange. Am. J. Physiol. Renal Physiol. 2008, 294(1):F212-F219.
10. Zhou J., et al. Critical role of TRPC6 channels in the formation of excitatory synapses. Nat. Neurosci. 2008, 11(7):741-743.
11. Li Y., et al. Essential role of TRPC channels in the guidance of nerve growth cones by brain-derived neurotrophic factor. Nature 2005, 434(7035):894-898.
12. Brownlow S.L., Sage S.O. Transient receptor potential protein subunit assembly and membrane distribution in human platelets. Thromb. Haemost. 2005, 94(4):839-845.
13. Hassock S.R., et al. Expression and role of TRPC proteins in human platelets: evidence that TRPC6 forms the store-independent calcium entry channel. Blood 2002, 100(8):2801-2811.
14. Yao X., Garland C.J. Recent developments in vascular endothelial cell transient receptor potential channels. Circ. Res. 2005, 97(9):853-863.
15. Dietrich A., et al. In vivo TRPC functions in the cardiopulmonary vasculature. Cell Calcium 2007, 42(2):233-244.
16. Rebecchi M.J., Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 2000, 80(4):1291-1335.
17. Dietrich A., et al. Functional characterization and physiological relevance of the TRPC3/6/7 subfamily of cation channels. Naunyn Schmiedebergs Arch. Pharmacol. 2005, 371(4):257-265.
18. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 2001, 70:281-312.
19. Berridge M.J. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu. Rev. Biochem. 1987, 56.
20. Winn M.P., et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005, 308(5729):1801-1804.
21. Reiser J., et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet. 2005, 37(7):739-744.
22. Kestila M., et al. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1998, 1(4):575-582.
23. Schlondorff J.S., Pollak M.R. TRPC6 in glomerular health and disease: what we know and what we believe. Semin. Cell Dev. Biol. 2006, 17(6):667-674.
24. Freichel M., et al. Functional role of TRPC proteins in native systems: implications from knockout and knock-down studies. J. Physiol. 2005, 567(Pt 1):59-66.
25. Foster R.R., et al. Flufenamic acid is a tool for investigating TRPC6-mediated calcium signalling in human conditionally immortalised podocytes and HEK293 cells. Cell Calcium 2009, 45(4):384-390.
26. Saleem M.A., et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 2002, 13(3):630-638.
27. Foster R.R., et al. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am. J. Physiol. Renal Physiol. 2005, 288(1):F48-57.
28. Satchell S.C., et al. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int. 2006, 69(9):1633-1640.
29. Foster R.R., et al. Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium. Am. J. Pathol. 2008.
30. Foster R.R., et al. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am. J. Physiol. Renal Physiol. 2003, 284(6):F1263-F1273.
31. Blasutig I.M., et al. Phosphorylated YDXV motifs and Nck SH2/SH3 adaptors act cooperatively to induce actin reorganization. Mol. Cell Biol. 2008, 28(6):2035-2046.
32. Trouet D., et al. Downregulation of TRPC6 by intact nephrin in the presence of human plasma-a protective mechanism for maintenance of podocyte process structure?. JASN 2005, F-PO456.
33. Krause E., et al. Depletion of intracellular calcium stores activates a calcium conducting nonselective cation current in mouse pancreatic acinar cells. J. Biol. Chem. 1996, 271(51):32523-32528.
34. Jardin I., et al. Dynamic interaction of hTRPC6 with the Orai1-STIM1 complex or hTRPC3 mediates its role in capacitative or non-capacitative Ca(2+) entry pathways. Biochem. J. 2009, 420(2):267-276.
35. Lee R.J., et al. Mechanism of action of the non-steroidal anti-inflammatory drug flufenamate on [Ca2+]i and Ca(2+)-activated currents in neurons. Cell Calcium 1996, 19(5):431-438.
36. Leuner K., et al. Hyperforin-a key constituent of St. John's wort specifically activates TRPC6 channels. Faseb J. 2007, 21(14):4101-4111.
37. Kobayashi N. Mechanism of the process formation; podocytes vs. neurons. Microsc. Res. Tech. 2002, 57(4):217-223.
38. 2+ stores potentiates sensory synaptic transmission. J. Neurosci. 2004, 24(3):762-771.
39. Thebault S., et al. Novel role of cold/menthol-sensitive transient receptor potential melastatine family member 8 (TRPM8) in the activation of store-operated channels in LNCaP human prostate cancer epithelial cells. J. Biol. Chem. 2005, 280(47):39423-39435.
40. Tu P., Brandolin G., Bouron A. The anti-inflammatory agent flufenamic acid depresses store-operated channels by altering mitochondrial calcium homeostasis. Neuropharmacology 2009, 56(6-7):1010-1016.
41. Kriz W. Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc. Res. Tech. 2002, 57(4):189-195.
42. Kaplan J.M., et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 2000, 24(3):251-256.
43. Boute N., et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 2000, 24(4):349-354.